Calumet Specialty Products Partners, L.P. (CLMT) Cash Flow Statement
Where CLMT’s cash came from and went, 2025
December 31, 2025 · U.S. dollars- Cash from operations
- $108.9M
- Capital expenditures
- $52.3M 1.3% of revenue
- Free cash flow
- $56.6M 1.4% margin
- Returned to shareholders
- —
- Change in cash
- $159.2M cash at year-end $205.1M
Drawn to scale: where the cash came from and how it was used. Hover for values.
CLMT operating cash flow, capex and free cash flow
CLMT cash flow trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | $4.1M2016 | $108.9M2025 | +44.0%/yr | |
| Capital expenditures | $139.4M2016 | $52.3M2025 | −10.3%/yr | |
| Free cash flow | −$135.3M2016 | $56.6M2025 | — | |
| Free cash flow margin | −3.8%2016 | 1.4%2025 | +5.1 pts | |
| Stock-based compensation | $5.6M2016 | −$4.5M2025 | — | |
| Dividends paid | $52.1M2016 | $02018 | −100.0% | |
| Share buybacks (net) | $1.8M2016 | $02024 | −100.0% | |
| Capex / revenue | 3.9%2016 | 1.3%2025 | −2.6 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
CLMT cash flow by activity
CLMT net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
CLMT cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | −$33.8M | −$222.0M | $48.1M | −$169.8M | −$260.1M | −$149.0M | −$43.6M | −$51.0M | −$31.3M | −$328.6M |
| Depreciation & amortization | $148.8M | $149.0M | $146.8M | $98.3M | $107.7M | $105.1M | $110.1M | $130.9M | $154.8M | $185.2M |
| Stock-based compensation | −$4.5M | $14.6M | $14.7M | $17.3M | $50.7M | $5.5M | $5.9M | −$1.2M | $11.6M | $5.6M |
| Change in working capital | −$3.1M | $10.2M | −$25.1M | −$189.5M | −$45.1M | −$38.3M | $78.9M | −$47.5M | −$105.7M | $7.8M |
| Other non-cash items | $1.5M | $1.8M | −$199.4M | $344.3M | $102.8M | $139.5M | $40.6M | $44.0M | −$55.9M | $134.1M |
| Cash from operating activities | $108.9M | −$46.4M | −$14.9M | $100.6M | −$44.0M | $62.8M | $191.9M | $75.2M | −$26.5M | $4.1M |
| Investing activities | ||||||||||
| Capital expenditures | −$52.3M | −$76.7M | −$271.8M | −$536.2M | −$82.9M | −$44.0M | −$54.9M | −$49.8M | −$70.0M | −$139.4M |
| Investments (net) | −$500,000 | −$76.7M | −$400.2M | −$536.0M | −$82.8M | −$46.3M | $5.0M | $6.1M | $453.4M | −$16.7M |
| Acquisitions & other investing | $96.9M | $76.7M | $400.2M | $786.2M | $82.9M | $44.0M | $64.4M | $52.0M | $70.0M | $1.9M |
| Cash from investing activities | $44.1M | −$76.7M | −$271.8M | −$286.0M | −$82.8M | −$46.3M | $14.5M | $8.3M | $453.4M | −$154.2M |
| Financing activities | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | $0 | $0 | −$52.1M |
| Share repurchases & issuance (net) | — | $0 | $0 | −$4.4M | $0 | $0 | $100,000 | $100,000 | $100,000 | −$1.8M |
| Net borrowing (repayment) | −$23.5M | $97.7M | $248.7M | −$286.7M | $88.9M | $105.7M | −$360.4M | −$451.4M | −$14.7M | $197.4M |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $100,000 | $0 | $0 |
| Other financing | $29.7M | $56.6M | $17.5M | $389.8M | $50.4M | −$31.9M | $17.3M | $9.1M | $97.8M | $5.2M |
| Cash from financing activities | $6.2M | $154.3M | $266.2M | $98.7M | $139.3M | $73.8M | −$343.0M | −$442.1M | $83.2M | $148.7M |
| Summary | ||||||||||
| Net change in cash | $159.2M | $31.2M | −$20.5M | −$2.9M | $12.5M | $90.3M | −$136.6M | −$358.6M | $510.1M | −$1.4M |
| Cash at end of period | $205.1M | $45.9M | $14.7M | $35.2M | $121.9M | $109.4M | $19.1M | $155.7M | $514.3M | $4.2M |
| Free cash flow | $56.6M | −$123.1M | −$286.7M | −$435.6M | −$126.9M | $18.8M | $137.0M | $25.4M | −$96.5M | −$135.3M |
| Free cash flow margin | 1.4% | −2.9% | −6.9% | −9.3% | −4.0% | 0.8% | 4.0% | 0.7% | −2.6% | −3.8% |
| Capex / revenue | 1.3% | 1.8% | 6.5% | 11.4% | 2.6% | 1.9% | 1.6% | 1.4% | 1.9% | 3.9% |
| Operating cash flow / net income | — | — | −0.31 | — | — | — | — | — | — | — |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$95.9M | −$317.0M | −$37.3M | $313.4M | −$147.9M | −$162.0M | −$40.7M | −$100.6M | −$38.3M | −$38.3M | −$46.6M | $99.8M |
| Depreciation & amortization | $34.6M | $41.4M | $44.6M | $18.8M | $36.7M | $46.7M | $40.9M | $45.3M | $45.9M | $45.9M | $59.3M | $43.7M |
| Stock-based compensation | $44.9M | $37.4M | −$4.5M | — | $4.5M | −$21.5M | $14.6M | — | — | — | $14.6M | $100,000 |
| Change in working capital | −$34.5M | −$86.4M | $51.0M | −$9.5M | −$4.1M | $300,000 | $9.6M | −$8.1M | $51.6M | $51.6M | $71.6M | $21.3M |
| Other non-cash items | $143.2M | $238.4M | $62.7M | −$222.3M | $113.4M | $25.9M | −$27.8M | $47.9M | $7.3M | $7.3M | −$106.4M | −$119.7M |
| Cash from operating activities | $92.3M | −$86.2M | $116.5M | $100.4M | $2.6M | −$110.6M | −$3.4M | −$15.5M | $66.5M | $66.5M | −$7.5M | $45.2M |
| Investing activities | ||||||||||||
| Capital expenditures | −$38.3M | −$13.2M | −$12.7M | −$8.4M | −$13.6M | −$17.6M | −$25.0M | −$16.7M | −$15.0M | −$15.0M | −$31.5M | −$32.1M |
| Investments (net) | — | — | — | −$8.4M | −$13.6M | $77.8M | −$25.0M | −$16.7M | −$15.0M | −$20.0M | −$31.5M | −$32.1M |
| Acquisitions & other investing | −$1.0M | −$500,000 | $1.0M | $8.4M | $13.6M | $17.6M | $25.0M | $16.7M | $15.0M | $20.0M | $31.5M | $32.1M |
| Cash from investing activities | −$39.3M | −$13.7M | −$11.7M | −$8.4M | −$13.6M | $77.8M | −$25.0M | −$16.7M | −$15.0M | −$15.0M | −$31.5M | −$32.1M |
| Financing activities | ||||||||||||
| Net borrowing (repayment) | −$77.0M | $109.0M | −$74.1M | −$120.8M | $4.8M | $166.6M | $50.5M | −$95.6M | — | — | — | — |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | −$4.8M | −$35.6M | −$200,000 | $12.8M | −$6.6M | $23.7M | −$18.5M | $155.5M | −$68.3M | −$68.3M | $33.3M | −$35.3M |
| Cash from financing activities | −$81.8M | $73.4M | −$74.3M | −$108.0M | −$1.8M | $190.3M | $32.0M | $59.9M | −$68.3M | −$68.3M | $33.3M | −$35.3M |
| Summary | ||||||||||||
| Net change in cash | −$28.8M | −$26.5M | $30.5M | −$16.0M | −$12.8M | $157.5M | $3.6M | $27.7M | −$16.8M | −$16.8M | −$5.7M | −$22.2M |
| Cash at end of period | $149.8M | $178.6M | $205.1M | $174.6M | $190.6M | $203.4M | $45.9M | $42.3M | $14.6M | $14.6M | $14.7M | $20.4M |
| Free cash flow | $54.0M | −$99.4M | $103.8M | $92.0M | −$11.0M | −$128.2M | −$28.4M | −$32.2M | $51.5M | $51.5M | −$39.0M | $13.1M |
| Free cash flow margin | 3.7% | −9.7% | 10.0% | 8.5% | −1.1% | −12.9% | −3.0% | −2.9% | 4.5% | 4.5% | −4.0% | 1.1% |
| Capex / revenue | 2.7% | 1.3% | 1.2% | 0.8% | 1.3% | 1.8% | 2.6% | 1.5% | 1.3% | 1.3% | 3.2% | 2.8% |
| Operating cash flow / net income | — | — | — | 0.32 | — | — | — | — | — | — | — | 0.45 |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
CLMT cash generation
In fiscal 2025 (ended December 31, 2025), Calumet generated $108.9 million of cash from operations and spent $52.3 million on capital expenditures, leaving free cash flow of $56.6 million, 1.4% of revenue. Cash and equivalents rose by $159.2 million over the year.
Related: CLMT income statement, CLMT balance sheet. See the CLMT stock overview for the latest quote and news.
CLMT cash flow FAQ
What is Calumet's free cash flow?
Calumet's free cash flow was $56.6 million in fiscal 2025: $108.9 million of operating cash flow minus $52.3 million of capital expenditures It was -$123.1 million a year earlier..
How much cash does Calumet generate from operations?
Calumet generated $108.9 million of cash from operating activities in fiscal 2025.
How much does Calumet spend on capital expenditures?
Calumet spent $52.3 million on capital expenditures in fiscal 2025, 1.3% of revenue, compared with $76.7 million the year before.